What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Cancer research, Cell biology, Internal medicine, Cancer and Immunology.
His work carried out in the field of Cancer research brings together such families of science as Apoptosis, KRAS, Downregulation and upregulation and Cell growth.
Paul Hofman has included themes like Autophagy and Transcription factor in his Cell biology study.
His biological study spans a wide range of topics, including Endocrinology and Oncology.
Paul Hofman usually deals with Cancer and limits it to topics linked to Lung cancer and Immunotherapy, Liquid biopsy, Biomarker and Carcinogenesis.
His study in Immunology is interdisciplinary in nature, drawing from both Cytotoxic T cell, Gene silencing and Receptor.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Migraine as a Risk Factor for Subclinical Brain Lesions (767 citations)
What are the main themes of his work throughout his whole career to date?
Paul Hofman spends much of his time researching Pathology, Internal medicine, Cancer research, Lung cancer and Oncology.
Pathology is often connected to Thyroid in his work.
Internal medicine is a component of his Lung and Circulating tumor cell studies.
Apoptosis is closely connected to Immunology in his research, which is encompassed under the umbrella topic of Cancer research.
His Lung cancer research focuses on Adenocarcinoma and how it relates to KRAS.
His research in Oncology intersects with topics in Targeted therapy, Chemotherapy and Immunotherapy.
He most often published in these fields:
- Pathology (24.41%)
- Internal medicine (21.53%)
- Cancer research (19.32%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (21.53%)
- Lung cancer (17.46%)
- Oncology (15.59%)
In recent papers he was focusing on the following fields of study:
Paul Hofman mainly focuses on Internal medicine, Lung cancer, Oncology, Cancer research and Immunotherapy.
In his study, which falls under the umbrella issue of Internal medicine, Metastasis is strongly linked to Cell.
In his research, Circulating tumor cell, Targeted therapy and Pathology is intimately related to Liquid biopsy, which falls under the overarching field of Lung cancer.
His studies deal with areas such as Immunohistochemistry, Predictive biomarker, Carcinoma, Melanoma and Lung as well as Oncology.
His study focuses on the intersection of Immunohistochemistry and fields such as Adenocarcinoma with connections in the field of Clone.
His Cancer research research includes themes of Transcriptome, Transcription factor, Gene, Downregulation and upregulation and Immune system.
Between 2018 and 2021, his most popular works were:
- Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy. (86 citations)
- Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? (58 citations)
- Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. (57 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Lung cancer, Internal medicine, Cancer research, Oncology and Immunohistochemistry.
His work on Lung cancer screening is typically connected to Context as part of general Lung cancer study, connecting several disciplines of science.
Paul Hofman works mostly in the field of Internal medicine, limiting it down to topics relating to Molecular pathology and, in certain cases, Concomitant, Gold standard, Clone and ROS1, as a part of the same area of interest.
His Cancer research research integrates issues from Transcriptome, Downregulation and upregulation, Gene, Long non-coding RNA and Epigenesis.
He combines subjects such as Predictive biomarker, Clinical trial, Lung and Immunotherapy with his study of Oncology.
His Immunohistochemistry research includes elements of Melanoma, Immune system, Potential biomarkers and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
